Your browser doesn't support javascript.
loading
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit, Barbara M; Nwakama, Patrick E; Buehler, Gary J; Conner, Dale P; Haidar, Sam H; Patel, Devvrat T; Yang, Yongsheng; Yu, Lawrence X; Woodcock, Janet.
Affiliation
  • Davit BM; Division of Bioequivalence II, Office of Generic Drugs, Office of Pharmaceutical Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Derwood, MD 20855, USA. barbara.davit@fda.hhs.gov
Ann Pharmacother ; 43(10): 1583-97, 2009 Oct.
Article in En | MEDLINE | ID: mdl-19776300
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Drugs, Generic / Drug Approval Type of study: Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Drugs, Generic / Drug Approval Type of study: Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States